Induced neural stem cells: a new tool for studying neural development and neurological disorders

Liu, Guanghui; Yi, Fei; Suzuki, Keiichiro; Qu, Jing; Belmonte, Juan Carlos Izpisúa

doi:10.1038/cr.2012.73

Cited by 24 publications

(18 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In addition, NPCs have been proposed as promising cell sources for cell replacement therapy of neurological diseases (Liu et al, 2012b). For these areas of study, experimental animals are indispensable models.…”

mentioning

confidence: 99%

Direct reprogramming of porcine fibroblasts to neural progenitor cells

Yang

et al. 2014

Protein Cell

Self Cite

View full text Add to dashboard Cite

mentioning

confidence: 99%

Direct reprogramming of porcine fibroblasts to neural progenitor cells

Yang

et al. 2014

Protein Cell

Self Cite

View full text Add to dashboard Cite

“…Table 1 summarizes a number of lineage reprogramming protocols that have been documented for the generation of induced neurons. The directly reprogrammed cells exhibit equivalent functionality to the cells differentiated from iPSCs or their in vivo counterparts and show no tumorigenicity when transplanted in vivo [21,22]. However, cells generated by this procedure may demonstrate restricted proliferative capacity, limited cell type diversity and even senescence [23], which may in turn substantially compromise their potential application in regenerative therapy.…”

Section: Transdifferentiation and Direct Reprogrammingmentioning

confidence: 99%

Regenerative Medicine for the Aging Brain

López-León¹,

Reggiani²,

Hereñú³

et al. 2014

Enliven:J Stem Cells Regen Med

View full text Add to dashboard Cite

In the central nervous system, cholinergic and dopaminergic (DA) neurons are among the cells most susceptible to the deleterious effects of age. Thus, the basal forebrain cholinergic system is known to undergo moderate neurodegenerative changes during normal aging as well as severe atrophy in Alzheimer's disease (AD). Parkinson's disease (PD), a degeneration of nigro-striatal DA neurons is the most conspicuous reflection of the vulnerability of DA neurons to age. In this context, cell reprogramming offers novel therapeutic possibilities for the treatment of these devastating diseases. In effect, the generation of induced pluripotent stem cells (iPSCs) from somatic cells demonstrated that adult mammalian cells can be reprogrammed to a pluripotent state by the overexpression of a few embryonic transcription factors (TF). This discovery fundamentally widened the research horizon in the fields of disease modeling and regenerative medicine. Although it is possible to re-differentiate iPSCs to specific somatic cell types, the tumorigenic potential of contaminating iPSCs that failed to differentiate, increases the risk for clinical application of somatic cells generated by this procedure. Therefore, reprogramming approaches that bypass the pluripotent stem cell state are being explored. A method called lineage reprogramming has been recently documented. It consists of the direct conversion of one adult cell type into another by transgenic expression of multiple lineage-specific TF or microRNAs. Another approach, termed direct reprogramming, features several advantages such as the use of universal TF system and the ability to generate a rejuvenated multipotent progenitor cell population, able to differentiate into specific cell types in response to a specific differentiation factors. These novel approaches offer a new promise for the treatment of pathologies associated with the loss of specific cell types as for instance, nigral DA neurons (in PD) or basal forebrain cholinergic neurons in the early stages of AD. The above topics are reviewed here. Conflict of InterestThe authors confirm that they have no conflicts of interest. Cell reprogramming is an emerging technology that offers two major advantages over ESCbased therapeutic approaches. The first one is related to the fact that iPSCs can be generated from easily accessible somatic cells from the patient (skin fibroblasts, for instance). The iPSCs derived from the patient's own cells will be autologous for her/him and therefore will not induce immunologic rejection when implanted. This is a necessary requirement for implementing genuine personalized regenerative medicine. The second advantage is of ethical nature and stems from the fact that the use of iPSCs does not require the destruction of embryos as is the case for conventional ESC therapy. NIH Public AccessAlthough it is possible to re-differentiate iPSCs into specific differentiated cell types by culturing such iPSCs in media supplemented with appropriate factors, the procedure as a whole is costly, a...

show abstract

“…While these problems continue to hamper in vitro differentiation studies with primary neural stem cells ES cells offer a simple and efficient alternative solution to overcome such concerns. Furthermore, several recent studies have shown the derivation of either neural stem cells (for review see [91]) or differentiated dopamine neurons [92e94] directly from fibroblasts using extrinsic expression of lineages specific transcription factors.…”

Section: Neural Stem Cellsmentioning

confidence: 99%

The Nervous System

Studer

2014

Principles of Tissue Engineering

View full text Add to dashboard Cite

Induced neural stem cells: a new tool for studying neural development and neurological disorders

Cited by 24 publications

References 19 publications

Direct reprogramming of porcine fibroblasts to neural progenitor cells

Direct reprogramming of porcine fibroblasts to neural progenitor cells

Regenerative Medicine for the Aging Brain

The Nervous System

Contact Info

Product

Resources

About